Showing results (511-520 of 1,751) with videos related to
Sort By:
Pageof 176
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serumJennifer A Westwood, William K Murray, Melanie Trivett, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
CpG-C oligodeoxynucleotides limit the deleterious effects of beta-adrenoceptor stimulation on NK cytotoxicity and metastatic disseminationYael Goldfarb, Marganit Benish, Ella Rosenne, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
Semiquantitation of mouse dendritic cell migration in vivo using cellular MRIGregory A Dekaban, Jonatan Snir, Bradly Shrum, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
Eradication of established B-cell lymphoma by CD19-specific murine T cells is dependent on host lymphopenic environment and can be mediated by CD4+ and CD8+ T cellsEleanor J Cheadle, Robert E Hawkins, Hayley Batha, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
IL-17 secreted by tumor reactive T cells induces IL-8 release by human renal cancer cellsTakashi Inozume, Ken-ichi Hanada, Qiong J Wang, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Vaccination with a recombinant protein encoding the tumor-specific antigen NY-ESO-1 elicits an A2/157-165-specific CTL repertoire structurally distinct and of reduced tumor reactivity than that elicited by spontaneous immune responses to NY-ESO-1-expressing TumorsGilles Bioley, Philippe Guillaume, Immanuel Luescher, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Treatment of malignant pleural effusion with the trifunctional antibody catumaxomab (Removab) (anti-EpCAM x Anti-CD3): results of a phase 1/2 studyMartin Sebastian, Philipp Kiewe, Wolfgang Schuette, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 17, 2012
Optimization of antitumor immunotherapy mediated by type III secretion system-based live attenuated bacterial vectorsYan Wang, Audrey Le Gouëllec, Hichem Chaker, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 17, 2012
Silencing of the TGF-β1 gene increases the immunogenicity of cells from human ovarian carcinomaHuafeng Wei, Pu Liu, Elizabeth Swisher, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2008
Positive selection and expansion of cytomegalovirus-specific CD4 and CD8 T cells in sealed systems: potential applications for adoptive cellular immunoreconstitutionGiuseppina Li Pira, Federico Ivaldi, Gino Tripodi, et al.Pageof 176